621 related articles for article (PubMed ID: 18821749)
21. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
[TBL] [Abstract][Full Text] [Related]
22. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and evaluation of 4,7-diamino-1,10-phenanthroline G-quadruplex ligands.
Nielsen MC; Borch J; Ulven T
Bioorg Med Chem; 2009 Dec; 17(24):8241-6. PubMed ID: 19896385
[TBL] [Abstract][Full Text] [Related]
24. Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure.
Rezler EM; Seenisamy J; Bashyam S; Kim MY; White E; Wilson WD; Hurley LH
J Am Chem Soc; 2005 Jul; 127(26):9439-47. PubMed ID: 15984871
[TBL] [Abstract][Full Text] [Related]
25. Structural diversity and extreme stability of unimolecular Oxytricha nova telomeric G-quadruplex.
Lee JY; Yoon J; Kihm HW; Kim DS
Biochemistry; 2008 Mar; 47(11):3389-96. PubMed ID: 18298084
[TBL] [Abstract][Full Text] [Related]
26. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence-based melting assays for studying quadruplex ligands.
De Cian A; Guittat L; Kaiser M; Saccà B; Amrane S; Bourdoncle A; Alberti P; Teulade-Fichou MP; Lacroix L; Mergny JL
Methods; 2007 Jun; 42(2):183-95. PubMed ID: 17472900
[TBL] [Abstract][Full Text] [Related]
28. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
[TBL] [Abstract][Full Text] [Related]
29. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA.
Liao SR; Zhou CX; Wu WB; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2012 Jul; 53():52-63. PubMed ID: 22513122
[TBL] [Abstract][Full Text] [Related]
30. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
Gunaratnam M; Neidle S
Methods Mol Biol; 2010; 613():303-13. PubMed ID: 19997892
[TBL] [Abstract][Full Text] [Related]
31. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
[TBL] [Abstract][Full Text] [Related]
33. Reduced or diminished stabilization of the telomere G-quadruplex and inhibition of telomerase by small chemical ligands under molecular crowding condition.
Chen Z; Zheng KW; Hao YH; Tan Z
J Am Chem Soc; 2009 Aug; 131(30):10430-8. PubMed ID: 19588966
[TBL] [Abstract][Full Text] [Related]
34. Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells.
Hampel SM; Sidibe A; Gunaratnam M; Riou JF; Neidle S
Bioorg Med Chem Lett; 2010 Nov; 20(22):6459-63. PubMed ID: 20932753
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
36. C-11 diamino cryptolepine derivatives NSC748392, NSC748393, and NSC748394: anticancer profile and G-quadruplex stabilization.
Lavrado J; Reszka AP; Moreira R; Neidle S; Paulo A
Bioorg Med Chem Lett; 2010 Dec; 20(23):7042-5. PubMed ID: 20952194
[TBL] [Abstract][Full Text] [Related]
37. Targeting telomerase and telomeres: a click chemistry approach towards highly selective G-quadruplex ligands.
Moorhouse AD; Haider S; Gunaratnam M; Munnur D; Neidle S; Moses JE
Mol Biosyst; 2008 Jun; 4(6):629-42. PubMed ID: 18493662
[TBL] [Abstract][Full Text] [Related]
38. Contribution of telomere G-quadruplex stabilization to the inhibition of telomerase-mediated telomere extension by chemical ligands.
Chen CY; Wang Q; Liu JQ; Hao YH; Tan Z
J Am Chem Soc; 2011 Sep; 133(38):15036-44. PubMed ID: 21846102
[TBL] [Abstract][Full Text] [Related]
39. Homogeneous selecting of a quadruplex-binding ligand-based gold nanoparticle fluorescence resonance energy transfer assay.
Jin Y; Li H; Bai J
Anal Chem; 2009 Jul; 81(14):5709-15. PubMed ID: 19527045
[TBL] [Abstract][Full Text] [Related]
40. Effects of a halogenated G-quadruplex ligand from the pyridine dicarboxamide series on the terminal sequence of XpYp telomere in HT1080 cells.
Sidibe A; Hamon F; Largy E; Gomez D; Teulade-Fichou MP; Trentesaux C; Riou JF
Biochimie; 2012 Dec; 94(12):2559-68. PubMed ID: 22796264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
